Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Pediatric Emergency Care|November 14, 2018
Acute Flaccid Paralysis in an 11-Year-OldLisa Schwartz, Rebecca Bishop, Jacqueline Le, et al.Contemporary Clinical Trials Communications|April 24, 2019
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancersJim Murray, Guy Pratt, Abe Jacob, et al.British Journal of Haematology|September 7, 2021
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapyJustin Loke, Marlen Metzner, Rebecca Boucher, et al.Bone Marrow Transplantation|August 27, 2021
Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trialRam Malladi, Ikhlaaq Ahmed, Graham McIlroy, et al.BMJ Open|January 29, 2025
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)Ronjon Chakraverty, Emma Kempshall, Fiona Dignan, et al.International Journal of Environmental Research and Public Health|June 10, 2022
Connecting Healthcare with Income Maximisation Services: A Systematic Review on the Health, Wellbeing and Financial Impacts for Families with Young ChildrenJade Burley, Nora Samir, Anna Price, et al.The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.BMC Plant Biology|February 19, 2008
Global gene expression analysis of apple fruit development from the floral bud to ripe fruitBart J Janssen, Kate Thodey, Robert J Schaffer, et al.Scientific Data|October 31, 2025
High-density Phenotype Data of Intermediate Phenotypes Associated with Stalk Lodging Resistance in MaizeBharath Kunduru, Norbert T Bokros, Kaitlin Tabaracci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2019
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY StudyPeter Hillmen, Andy C Rawstron, Kristian Brock, et al.Pageof 2